Dr. David A. Wohl, MD
Claim this profileUnc Aids Crs (3201)
Studies Hepatitis
Studies Infections
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials David A. Wohl, MD is currently running
More about David A. Wohl, MD
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical TrialTreatments David A. Wohl, MD has experience with
- Glecaprevir
- Pibrentasvir
- Doravirine
Breakdown of trials David A. Wohl, MD has run
Hepatitis
Infections
Contagious Diseases
Hepatitis A
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David A. Wohl, MD specialize in?
David A. Wohl, MD focuses on Hepatitis and Infections. In particular, much of their work with Hepatitis has involved treating patients, or patients who are undergoing treatment.
Is David A. Wohl, MD currently recruiting for clinical trials?
Yes, David A. Wohl, MD is currently recruiting for 1 clinical trial in Chapel Hill North Carolina. If you're interested in participating, you should apply.
Are there any treatments that David A. Wohl, MD has studied deeply?
Yes, David A. Wohl, MD has studied treatments such as Glecaprevir, Pibrentasvir, Doravirine.
What is the best way to schedule an appointment with David A. Wohl, MD?
Apply for one of the trials that David A. Wohl, MD is conducting.
What is the office address of David A. Wohl, MD?
The office of David A. Wohl, MD is located at: Unc Aids Crs (3201), Chapel Hill, North Carolina 27514 United States. This is the address for their practice at the Unc Aids Crs (3201).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.